How do you proceed after a patient has a partial response following 6 cycles of cisplatin + paclitaxel + bevacizumab +/- pembrolizumab for metastatic SCC of the cervix?  

Assuming minimal toxicities except fatigue from long, recurrent infusions.



Answer from: at Community Practice

Answer from: at Community Practice